CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

UBS Adjusts Price Target on Biogen to $270 From $240, Maintains Buy Rating

Positive
AI Analysis

Summary

UBS raised its price target on Biogen to $270 from $240 while maintaining a Buy rating.

Importance:2/10
Sentiment:
0.30
price_targetanalyst_ratingvaluation
Related Companies

Read the original article

Published by yahoo_finance on October 9, 2026 1:54 PM

Read Original